Pneumococcal Meningitis Before and After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13, Impact on Pediatric Hospitalization in Public and Nonpublic Institutions, in Uruguay

This is the first study showing the impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in Latin America; a significant (63.5%) reduction in hospitalization was observed during the first 6 years after starting vaccination. A 90% reduction of pneumococcal conjugate vaccines...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Pediatric infectious disease journal 2017-10, Vol.36 (10), p.1000-1001
Hauptverfasser: Pírez, María Catalina, Mota, María Inés, Giachetto, Gustavo, Sánchez Varela, Mercedes, Galazka, Jeannette, Gutierrez, Stella, Varela, Adriana, Picón, Teresa, Algorta, Gabriela
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1001
container_issue 10
container_start_page 1000
container_title The Pediatric infectious disease journal
container_volume 36
creator Pírez, María Catalina
Mota, María Inés
Giachetto, Gustavo
Sánchez Varela, Mercedes
Galazka, Jeannette
Gutierrez, Stella
Varela, Adriana
Picón, Teresa
Algorta, Gabriela
description This is the first study showing the impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in Latin America; a significant (63.5%) reduction in hospitalization was observed during the first 6 years after starting vaccination. A 90% reduction of pneumococcal conjugate vaccines 7/13 serotypes was observed (P < 0.0001). After vaccination, all strains were penicillin susceptible. Mortality had a reduction of 71%.
doi_str_mv 10.1097/INF.0000000000001671
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1915346969</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1915346969</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3561-3a6d8acee2ba5302f913da5c92524096e3d3eb3ff548637836910b6dbdf9dc543</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EotvCGyDkI4dua8eJEx_LitKVSumBhWPk2JNdl8QO_kPVPhzPhldZEHBgLqPR_L5vpPkQekXJGSWiPl_fXJ6RP4rymj5BC1qxYklEUz9FC9IIumScN0foOIS7DLGSkufoqGg4p4LzBfpxayGNTjml5IA_gDV2a6IJ-C30zgOWVuOLPoLHG2u-gw-Z-iyVMlZG4yz-YuIO_-WxcvYubWWEAwcB1-eUneL1OEkVcRbdgjYyeqPwlQuTiXIwj7OdycvUDXmzP3zj7DRPaxuiiWnPhNM9tfFpm-TDC_Ssl0OAl4d-gjaX7z6trpbXH9-vVxfXS8Uqnn8guW6kAig6WTFS9IIyLSsliqooieDANIOO9X1VNpzVDeOCko7rTvdCq6pkJ-jN7Dt59y1BiO1ogoJhkBZcCi0V-e8lF1xktJxR5V0IHvp28maU_qGlpN0n1-bk2n-Ty7LXhwupG0H_Fv2KKgPNDNy7IecRvg7pHny7AznE3f-9fwL-Vqha</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1915346969</pqid></control><display><type>article</type><title>Pneumococcal Meningitis Before and After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13, Impact on Pediatric Hospitalization in Public and Nonpublic Institutions, in Uruguay</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Pírez, María Catalina ; Mota, María Inés ; Giachetto, Gustavo ; Sánchez Varela, Mercedes ; Galazka, Jeannette ; Gutierrez, Stella ; Varela, Adriana ; Picón, Teresa ; Algorta, Gabriela</creator><creatorcontrib>Pírez, María Catalina ; Mota, María Inés ; Giachetto, Gustavo ; Sánchez Varela, Mercedes ; Galazka, Jeannette ; Gutierrez, Stella ; Varela, Adriana ; Picón, Teresa ; Algorta, Gabriela</creatorcontrib><description>This is the first study showing the impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in Latin America; a significant (63.5%) reduction in hospitalization was observed during the first 6 years after starting vaccination. A 90% reduction of pneumococcal conjugate vaccines 7/13 serotypes was observed (P &lt; 0.0001). After vaccination, all strains were penicillin susceptible. Mortality had a reduction of 71%.</description><identifier>ISSN: 0891-3668</identifier><identifier>EISSN: 1532-0987</identifier><identifier>DOI: 10.1097/INF.0000000000001671</identifier><identifier>PMID: 28661966</identifier><language>eng</language><publisher>United States: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Heptavalent Pneumococcal Conjugate Vaccine - administration &amp; dosage ; Heptavalent Pneumococcal Conjugate Vaccine - therapeutic use ; Hospitalization - statistics &amp; numerical data ; Hospitals, Pediatric ; Humans ; Immunization - statistics &amp; numerical data ; Infant ; Meningitis, Pneumococcal - epidemiology ; Meningitis, Pneumococcal - prevention &amp; control ; Pneumococcal Vaccines - administration &amp; dosage ; Pneumococcal Vaccines - therapeutic use ; Streptococcus pneumoniae ; Uruguay - epidemiology</subject><ispartof>The Pediatric infectious disease journal, 2017-10, Vol.36 (10), p.1000-1001</ispartof><rights>Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3561-3a6d8acee2ba5302f913da5c92524096e3d3eb3ff548637836910b6dbdf9dc543</citedby><cites>FETCH-LOGICAL-c3561-3a6d8acee2ba5302f913da5c92524096e3d3eb3ff548637836910b6dbdf9dc543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28661966$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pírez, María Catalina</creatorcontrib><creatorcontrib>Mota, María Inés</creatorcontrib><creatorcontrib>Giachetto, Gustavo</creatorcontrib><creatorcontrib>Sánchez Varela, Mercedes</creatorcontrib><creatorcontrib>Galazka, Jeannette</creatorcontrib><creatorcontrib>Gutierrez, Stella</creatorcontrib><creatorcontrib>Varela, Adriana</creatorcontrib><creatorcontrib>Picón, Teresa</creatorcontrib><creatorcontrib>Algorta, Gabriela</creatorcontrib><title>Pneumococcal Meningitis Before and After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13, Impact on Pediatric Hospitalization in Public and Nonpublic Institutions, in Uruguay</title><title>The Pediatric infectious disease journal</title><addtitle>Pediatr Infect Dis J</addtitle><description>This is the first study showing the impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in Latin America; a significant (63.5%) reduction in hospitalization was observed during the first 6 years after starting vaccination. A 90% reduction of pneumococcal conjugate vaccines 7/13 serotypes was observed (P &lt; 0.0001). After vaccination, all strains were penicillin susceptible. Mortality had a reduction of 71%.</description><subject>Heptavalent Pneumococcal Conjugate Vaccine - administration &amp; dosage</subject><subject>Heptavalent Pneumococcal Conjugate Vaccine - therapeutic use</subject><subject>Hospitalization - statistics &amp; numerical data</subject><subject>Hospitals, Pediatric</subject><subject>Humans</subject><subject>Immunization - statistics &amp; numerical data</subject><subject>Infant</subject><subject>Meningitis, Pneumococcal - epidemiology</subject><subject>Meningitis, Pneumococcal - prevention &amp; control</subject><subject>Pneumococcal Vaccines - administration &amp; dosage</subject><subject>Pneumococcal Vaccines - therapeutic use</subject><subject>Streptococcus pneumoniae</subject><subject>Uruguay - epidemiology</subject><issn>0891-3668</issn><issn>1532-0987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9u1DAQxi0EotvCGyDkI4dua8eJEx_LitKVSumBhWPk2JNdl8QO_kPVPhzPhldZEHBgLqPR_L5vpPkQekXJGSWiPl_fXJ6RP4rymj5BC1qxYklEUz9FC9IIumScN0foOIS7DLGSkufoqGg4p4LzBfpxayGNTjml5IA_gDV2a6IJ-C30zgOWVuOLPoLHG2u-gw-Z-iyVMlZG4yz-YuIO_-WxcvYubWWEAwcB1-eUneL1OEkVcRbdgjYyeqPwlQuTiXIwj7OdycvUDXmzP3zj7DRPaxuiiWnPhNM9tfFpm-TDC_Ssl0OAl4d-gjaX7z6trpbXH9-vVxfXS8Uqnn8guW6kAig6WTFS9IIyLSsliqooieDANIOO9X1VNpzVDeOCko7rTvdCq6pkJ-jN7Dt59y1BiO1ogoJhkBZcCi0V-e8lF1xktJxR5V0IHvp28maU_qGlpN0n1-bk2n-Ty7LXhwupG0H_Fv2KKgPNDNy7IecRvg7pHny7AznE3f-9fwL-Vqha</recordid><startdate>201710</startdate><enddate>201710</enddate><creator>Pírez, María Catalina</creator><creator>Mota, María Inés</creator><creator>Giachetto, Gustavo</creator><creator>Sánchez Varela, Mercedes</creator><creator>Galazka, Jeannette</creator><creator>Gutierrez, Stella</creator><creator>Varela, Adriana</creator><creator>Picón, Teresa</creator><creator>Algorta, Gabriela</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201710</creationdate><title>Pneumococcal Meningitis Before and After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13, Impact on Pediatric Hospitalization in Public and Nonpublic Institutions, in Uruguay</title><author>Pírez, María Catalina ; Mota, María Inés ; Giachetto, Gustavo ; Sánchez Varela, Mercedes ; Galazka, Jeannette ; Gutierrez, Stella ; Varela, Adriana ; Picón, Teresa ; Algorta, Gabriela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3561-3a6d8acee2ba5302f913da5c92524096e3d3eb3ff548637836910b6dbdf9dc543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Heptavalent Pneumococcal Conjugate Vaccine - administration &amp; dosage</topic><topic>Heptavalent Pneumococcal Conjugate Vaccine - therapeutic use</topic><topic>Hospitalization - statistics &amp; numerical data</topic><topic>Hospitals, Pediatric</topic><topic>Humans</topic><topic>Immunization - statistics &amp; numerical data</topic><topic>Infant</topic><topic>Meningitis, Pneumococcal - epidemiology</topic><topic>Meningitis, Pneumococcal - prevention &amp; control</topic><topic>Pneumococcal Vaccines - administration &amp; dosage</topic><topic>Pneumococcal Vaccines - therapeutic use</topic><topic>Streptococcus pneumoniae</topic><topic>Uruguay - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pírez, María Catalina</creatorcontrib><creatorcontrib>Mota, María Inés</creatorcontrib><creatorcontrib>Giachetto, Gustavo</creatorcontrib><creatorcontrib>Sánchez Varela, Mercedes</creatorcontrib><creatorcontrib>Galazka, Jeannette</creatorcontrib><creatorcontrib>Gutierrez, Stella</creatorcontrib><creatorcontrib>Varela, Adriana</creatorcontrib><creatorcontrib>Picón, Teresa</creatorcontrib><creatorcontrib>Algorta, Gabriela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Pediatric infectious disease journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pírez, María Catalina</au><au>Mota, María Inés</au><au>Giachetto, Gustavo</au><au>Sánchez Varela, Mercedes</au><au>Galazka, Jeannette</au><au>Gutierrez, Stella</au><au>Varela, Adriana</au><au>Picón, Teresa</au><au>Algorta, Gabriela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pneumococcal Meningitis Before and After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13, Impact on Pediatric Hospitalization in Public and Nonpublic Institutions, in Uruguay</atitle><jtitle>The Pediatric infectious disease journal</jtitle><addtitle>Pediatr Infect Dis J</addtitle><date>2017-10</date><risdate>2017</risdate><volume>36</volume><issue>10</issue><spage>1000</spage><epage>1001</epage><pages>1000-1001</pages><issn>0891-3668</issn><eissn>1532-0987</eissn><abstract>This is the first study showing the impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in Latin America; a significant (63.5%) reduction in hospitalization was observed during the first 6 years after starting vaccination. A 90% reduction of pneumococcal conjugate vaccines 7/13 serotypes was observed (P &lt; 0.0001). After vaccination, all strains were penicillin susceptible. Mortality had a reduction of 71%.</abstract><cop>United States</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>28661966</pmid><doi>10.1097/INF.0000000000001671</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0891-3668
ispartof The Pediatric infectious disease journal, 2017-10, Vol.36 (10), p.1000-1001
issn 0891-3668
1532-0987
language eng
recordid cdi_proquest_miscellaneous_1915346969
source MEDLINE; Journals@Ovid Complete
subjects Heptavalent Pneumococcal Conjugate Vaccine - administration & dosage
Heptavalent Pneumococcal Conjugate Vaccine - therapeutic use
Hospitalization - statistics & numerical data
Hospitals, Pediatric
Humans
Immunization - statistics & numerical data
Infant
Meningitis, Pneumococcal - epidemiology
Meningitis, Pneumococcal - prevention & control
Pneumococcal Vaccines - administration & dosage
Pneumococcal Vaccines - therapeutic use
Streptococcus pneumoniae
Uruguay - epidemiology
title Pneumococcal Meningitis Before and After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13, Impact on Pediatric Hospitalization in Public and Nonpublic Institutions, in Uruguay
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T23%3A59%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pneumococcal%20Meningitis%20Before%20and%20After%20Universal%20Vaccination%20With%20Pneumococcal%20Conjugate%20Vaccines%207/13,%20Impact%20on%20Pediatric%20Hospitalization%20in%20Public%20and%20Nonpublic%20Institutions,%20in%20Uruguay&rft.jtitle=The%20Pediatric%20infectious%20disease%20journal&rft.au=P%C3%ADrez,%20Mar%C3%ADa%20Catalina&rft.date=2017-10&rft.volume=36&rft.issue=10&rft.spage=1000&rft.epage=1001&rft.pages=1000-1001&rft.issn=0891-3668&rft.eissn=1532-0987&rft_id=info:doi/10.1097/INF.0000000000001671&rft_dat=%3Cproquest_cross%3E1915346969%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1915346969&rft_id=info:pmid/28661966&rfr_iscdi=true